Cardlytics, Inc. — Director's Dealing 2020

Apr 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-04-15

Reporting Person: Grimes Scott D. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-15	Common Stock	S	9376	$42.68	Disposed	370055	Direct
2020-04-15	Common Stock	S	25656	$43.45	Disposed	344399	Direct
2020-04-15	Common Stock	S	2468	$44.06	Disposed	341931	Direct
2020-04-16	Common Stock	S	20906	$42.79	Disposed	321025	Direct
2020-04-16	Common Stock	S	16194	$43.88	Disposed	304831	Direct
2020-04-16	Common Stock	S	400	$44.30	Disposed	304431	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	137112	Indirect

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018, as amended March 12, 2020.

F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $42.01 to $43.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6) and (7) to this Form 4.

F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $43.01 to $44.00, inclusive.

F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $44.01 to $44.33, inclusive.

F5: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $42.29 to $43.28, inclusive.

F6: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $43.29 to $44.15, inclusive.

F7: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $44.29 to $44.32, inclusive.

F8: The reportable securities are held by the 2013 Scott Grimes GRAT UAD.